GHTF (Global Harmonisation Task Force) issues global guidelines on vigilance exchange and auditing
This article was originally published in Clinica
Two key documents encouraging global convergence of medical devices rules, concerning vigilance and auditing, have been issued by the Global Harmonisation Task Force. Known as "final" documents, these have been endorsed at a GHTF plenary session, which means that all five founding members of the GHTF (Australia, Canada, the EU, Japan and the US) are committed to adopting/implementing them.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.